LANOLIN, PETROLATUM

N/A

Manufactured by Family Dollar Services Inc

611 FDA adverse event reports analyzed

Last updated: 2026-04-15

About LANOLIN, PETROLATUM

LANOLIN, PETROLATUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Family Dollar Services Inc. The most commonly reported adverse reactions for LANOLIN, PETROLATUM include NAUSEA, FATIGUE, DIARRHOEA, DYSPNOEA, INSOMNIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LANOLIN, PETROLATUM.

Top Adverse Reactions

NAUSEA23 reports
FATIGUE19 reports
DIARRHOEA17 reports
DYSPNOEA16 reports
INSOMNIA15 reports
DIZZINESS14 reports
HEADACHE14 reports
MALAISE13 reports
PYREXIA13 reports
VOMITING13 reports
DRUG INEFFECTIVE12 reports
PAIN11 reports
ASTHENIA10 reports
DEATH9 reports
FALL9 reports
PAIN IN EXTREMITY9 reports
PNEUMONIA9 reports
ABDOMINAL PAIN8 reports
DECREASED APPETITE8 reports
DEHYDRATION8 reports
MUSCULAR WEAKNESS8 reports
OFF LABEL USE8 reports
ANAEMIA7 reports
ARTHRALGIA7 reports
DEPRESSION7 reports
HAEMOGLOBIN DECREASED7 reports
MUSCULOSKELETAL PAIN7 reports
VISION BLURRED7 reports
WEIGHT DECREASED7 reports
ALOPECIA6 reports
BACK PAIN6 reports
CHEST PAIN6 reports
COUGH6 reports
MEMORY IMPAIRMENT6 reports
PRODUCT USE ISSUE6 reports
RASH6 reports
SOMNOLENCE6 reports
URTICARIA6 reports
WHITE BLOOD CELL COUNT DECREASED6 reports
ABDOMINAL DISCOMFORT5 reports
DYSPEPSIA5 reports
EYE PAIN5 reports
FEELING ABNORMAL5 reports
FLUSHING5 reports
HYPOAESTHESIA5 reports
LOWER RESPIRATORY TRACT INFECTION5 reports
MUSCLE SPASMS5 reports
NASOPHARYNGITIS5 reports
PERIPHERAL SWELLING5 reports
PRURITUS5 reports
PULMONARY EMBOLISM5 reports
TREMOR5 reports
WHEEZING5 reports
ABDOMINAL DISTENSION4 reports
ABDOMINAL PAIN UPPER4 reports
BALANCE DISORDER4 reports
BRONCHITIS4 reports
CEREBROVASCULAR ACCIDENT4 reports
CONFUSIONAL STATE4 reports
CONSTIPATION4 reports
COVID 194 reports
DRUG INTERACTION4 reports
ERYTHEMA4 reports
FEELING HOT4 reports
HOSPITALISATION4 reports
HYPERTENSION4 reports
HYPOTENSION4 reports
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS4 reports
INFLUENZA4 reports
INFUSION RELATED REACTION4 reports
MUSCULOSKELETAL STIFFNESS4 reports
OEDEMA PERIPHERAL4 reports
PRODUCT DOSE OMISSION ISSUE4 reports
PRODUCT USE COMPLAINT4 reports
RED BLOOD CELL COUNT DECREASED4 reports
SINUSITIS4 reports
SPEECH DISORDER4 reports
URINARY TRACT INFECTION4 reports
ABNORMAL LOSS OF WEIGHT3 reports
APPLICATION SITE PAIN3 reports
ASTHMA3 reports
BLOOD POTASSIUM DECREASED3 reports
BLOOD PRESSURE DECREASED3 reports
BRADYCARDIA3 reports
COLITIS3 reports
CONDITION AGGRAVATED3 reports
CONTUSION3 reports
DENTAL CARIES3 reports
DYSPHAGIA3 reports
GENERAL PHYSICAL HEALTH DETERIORATION3 reports
HYPERSENSITIVITY3 reports
HYPOCHROMIC ANAEMIA3 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION3 reports
INJECTION SITE ERYTHEMA3 reports
INJECTION SITE REACTION3 reports
INJURY3 reports
INTENTIONAL PRODUCT USE ISSUE3 reports
JOINT SWELLING3 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES3 reports
MIGRAINE3 reports

Report Outcomes

Out of 241 classified reports for LANOLIN, PETROLATUM:

Serious 68.0%Non-Serious 32.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female156 (66.4%)
Male79 (33.6%)

Reports by Age

Age 748 reports
Age 417 reports
Age 556 reports
Age 606 reports
Age 686 reports
Age 716 reports
Age 445 reports
Age 545 reports
Age 565 reports
Age 695 reports
Age 735 reports
Age 404 reports
Age 574 reports
Age 584 reports
Age 764 reports
Age 824 reports
Age 133 reports
Age 183 reports
Age 323 reports
Age 453 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with LANOLIN, PETROLATUM?

This profile reflects 611 FDA FAERS reports that mention LANOLIN, PETROLATUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for LANOLIN, PETROLATUM?

Frequently reported terms in FAERS include NAUSEA, FATIGUE, DIARRHOEA, DYSPNOEA, INSOMNIA, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures LANOLIN, PETROLATUM?

Labeling and FAERS entries often list Family Dollar Services Inc in connection with LANOLIN, PETROLATUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.